Evaluation of lipid-based drug delivery system (Phytosolve) on oral bioavailability of dibudipine

Iranian Journal of Pharmaceutical Research

Volumn 13, Issue 4, 2014, Pages 1149-1156

  Keyhanfar, Fariborz ^a   Khani, Samira ^a   Bohlooli, Shahab ^b  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ARDABIL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bioavailability; Dibudipine; Lipid based formulation; Phytosolve; Solubility

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIBUDIPINE; UNCLASSIFIED DRUG;

ANALYTICAL PARAMETERS; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DILUTION; DROPLET SIZE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG RETENTION; DRUG SCREENING; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF QUANTITATION; LINEARITY; LIPID BASED DRUG DELIVERY SYSTEM; MALE; MAXIMUM PLASMA CONCENTRATION; MEASUREMENT ACCURACY; MEASUREMENT PRECISION; NONHUMAN; PARTICLE SIZE; PLASMA CONCENTRATION-TIME CURVE; POLY DISPERSITY INDEX; PRODUCT RECOVERY; RAT; ROBUSTNESS; TIME TO MAXIMUM PLASMA CONCENTRATION; TRANSMISSION ELECTRON MICROSCOPY; TRANSPARENCY; WEIGHT, MASS AND SIZE; ZETA POTENTIAL;

EID: 84907287529     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Mahmoudian M, Mirkhani H, Nehardani Z and Ghiaee S. Synthesis and biological activity of two new calcium-channel blockers, mebudipine and dibudipine. J. Pharm. Pharmacol. (1997) 49: 1229-1233.
2. Mirkhani H, Omrani GR, Ghiaee S and Mahmoudian M. Effects of mebudipine and dibudipine, two new calcium-channel blockers, on rat left atrium, rat blood pressure and human internal mammary artery. J. Pharm. Pharmacol. (1999) 51: 617-622.
3. Bohlooli S, Mahmoudian M, Skellern G, Grant M and Tettey J. Metabolism of the dihydropyridine calcium channel blockers mebudipine and dibudipine by isolated rat hepatocytes. J. Pharm. Pharmacol. (2004) 56: 1469-1474.
4. Bohlooli S, Keyhanfar F, Ghiaee S and Mahmoudian M. Application of a new high performance liquid chromatography method to the pharmacokinetics of dibudipine in rats. J. Pharm. Sci. (2003) 6: 346-3451.
5. Gannu R, Palem CR, Yamsani VV, Yamsani SK and Yamsani MR. Enhanced bioavailability of lacidipine via microemulsion based transdermal gels: Formulation optimization, ex-vivo and in-vivo characterization. Int. J. Pharm. (2010) 388: 231-241.
6. Choi HG, Kim DD, Won Jun H, Yoo BK and Yong CS. Improvement of dissolution and bioavailability of nitrendipine by inclusion in hydroxypropyl-β- cyclodextrin. Drug Dev. Indust. Pharm. (2003) 29: 1085-1094.
7. Sharif Makhmalzadeh B, Torabi SH and Azarpanah A. Optimization of ibuprofen delivery through rat skin from traditional and novel nanoemulsion formulations. Iran. J. Pharm. Res. (2012) 11: 47-58.
8. Hadian Z, Sahari MA, Moghimi HR and Barzegar M. Formulation, Characterization and optimization of liposomes containing eicosapentaenoic and docosahexaenoic acids; a methodology approach. Iran. J. Pharm. Res. (2014) 13: 393-404.
9. Bunjes H. Lipid nanoparticles for the delivery of poorly water-soluble drugs. J. Pharm. Pharmacol. (2010) 62: 1637-1645.
10. Wajda R. Emulsive Water-soluble Concentrates. WIPO, Patentscope, Pub. No.WO/2004/047791 (2003).
11. Shah AK and Agnihotri SA. Recent advances and novel strategies in pre-clinical formulation development: An overview. J. Controlled Release (2011) 156: 281-296.
12. Thrivikraman K, Huot RL and Plotsky PM. Jugular vein catheterization for repeated blood sampling in the unrestrained conscious rat. Brain Res. Protocols (2002) 10: 84-94.
13. Hedaya MA. Basic Pharmacokinetics: Taylor & Francis, United States of America (2012) 159-165.
14. Gershanik T and Benita S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Europ. J. Pharm. Biopharm. (2000) 50: 179-188.
15. Stuchlík M and Zak S. Lipid-based vehicle for oral drug delivery. Biomed. Papers-Palacky Univ. Olomouc. (2000) 145: 17-26.
16. Wajda R, Zirkel J and Sauter K. NanoSolve: An advanced carrier system for cosmetic application. Cosmetic Sci. Technol. (2009) 1: 11-14.
17. Lawrence MJ and Rees GD. Microemulsion-based media as novel drug delivery systems. Adv. Drug Deliv Rev. (2000) 45: 89-121.
18. Moreno MA, Ballesteros MP and Frutos P. Lecithin- based oil-in-water microemulsions for parenteral use: Pseudoternary phase diagrams, characterization and toxicity studies. J. Pharm. Sci. (2003) 92: 1428-1437.
19. Wajda R, Zirkel J and Schaffer T. Increase of bioavailability of coenzyme Q10 and vitamin E. J. Med. Food (2007) 10: 731-734.
20. Trevaskis NL, Porter CJ and Charman WN. The lymph lipid precursor pool is a key determinant of intestinal lymphatic drug transport. J. Pharmacol. Exper. Therapeutics (2006) 316: 881-891.
21. Sun C, Wang J, Liu J, Qiu L, Zhang W and Zhang L. Liquid proliposomes of nimodipine drug delivery system: preparation, characterization, and pharmacokinetics. AAPS Pharm. Sci. Tech. (2013) 14: 332-338.